文献速递肾癌与肾肿瘤

组织学类型及亚型对中高危和高危肾细胞癌肾切除术后生存结局的影响:SEER数据库发现

Influence of Histologic Types and Subtypes on Survival Outcomes of Intermediate-High and High-Risk Renal Cell Carcinoma Following Nephrectomy: Findings From the SEER Database.
PubMed 文献 · Urology · 2021-09-04

本研究利用SEER数据库分析中高危和高危肾细胞癌肾切除术后患者,采用Kaplan-Meier曲线和多变量Cox回归评估组织学类型对总生存(OS)和癌症特异性生存(CSS)的影响。结果显示,与透明细胞亚型相比,嫌色细胞亚型OS和CSS更高,乳头状亚型相似,肉瘤样亚型更差;高危疾病较中高危疾病OS和CSS更低。

要点

  • 嫌色细胞亚型OS和CSS优于透明细胞亚型。
  • 肉瘤样亚型OS和CSS显著差于透明细胞亚型。
  • 高危疾病OS和CSS低于中高危疾病。

核心结论

  • 组织学亚型与中高危和高危肾细胞癌肾切除术后的生存结局独立相关。

研究设计与样本

  • 基于SEER项目数据识别接受肾切除术的中高危或高危肾细胞癌患者。
  • 采用未调整Kaplan-Meier曲线和多变量Cox回归分析评估组织学类型对OS和CSS的风险。

主要发现

  • OS方面,与透明细胞亚型相比,嫌色细胞HR=0.58(95%CI 0.47-0.70;P<.0001),乳头状HR=0.90(95%CI 0.80-1.02;P=.11),肉瘤样HR=3.17(95%CI 2.70-3.72;P<.0001)。
  • CSS方面,与透明细胞亚型相比,嫌色细胞HR=0.47(95%CI 0.35-0.63;P<.0001),乳头状HR=0.91(95%CI 0.77-1.08;P=.28),肉瘤样HR=4.19(95%CI 3.50-5.02;P<.0001)。
  • 高危疾病与中高危疾病相比,OS的HR=2.35(95%CI 2.01-2.74;P<.0001),CSS的HR=2.86(95%CI 2.39-3.43;P<.0001)。

临床怎么用

  • 对于中高危和高危肾细胞癌肾切除术后患者,组织学亚型可辅助风险分层和预后判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To understand the influence of histologic subtypes on the survival outcomes of intermediate-high and high-risk renal cell carcinoma (RCC) following nephrectomy. METHODS: This study employed data files from the SEER Program to identify patients diagnosed with intermediate-high or high risk RCC and treated with nephrectomy. Unadjusted Kaplan Meier curves, and multivariable Cox regression analyses were applied to estimate the hazards of histologic types for overall survival (OS) and cancer-specific survival (CSS). RESULTS: OS was higher for chromophobe (HR=0.58, 95% CI 0.47-0.70; P<.0001), similar for papillary (HR=0.90, 95% CI 0.80-1.02; P=.11) and worse for sarcomatoid (HR=3.17, 95% CI 2.70-3.72; P<.0001) subtypes relative to the clear cell subtype. OS was lower in the high-risk disease (HR=2.35, 95% CI 2.01-2.74; P <.0001) versus intermediate-high risk disease. CSS was higher for chromophobe (HR=0.47, 95% CI 0.35-0.63; P<.0001), similar for papillary (HR=0.91, 95% CI 0.77-1.08; P=.28) and worse for sarcomatoid (HR=4.19, 95% CI 3.50-5.02; P<.0001) subtypes relative to the clear cell subtype. CSS was lower for the high-risk disease (HR=2.86, 95%CI 2.39-3.43; P <.0001) relative to intermediate-high risk disease.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Ikuemonisan J, Togun A, Oyejinmi I, et al. Influence of Histologic Types and Subtypes on Survival Outcomes of Intermediate-High and High-Risk Renal Cell Carcinoma Following Nephrectomy: Findings From the SEER Database. Urology. 2021. PMID: 34492287. doi:10.1016/j.urology.2021.08.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。